“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free




Volume 40, Number 2 January 31, 2002 BACILLUS CALMETTE-GURIN (Intravesical) Prostate Abscess (First Report*) No. 14 A 47-year-old male patient developed perineal pain approximately three years after starting intravesical therapy with bacillus Calmette-Gurin for bladder carcinoma. A physical examination was normal with the exception of a slight induration on the right side if the prostate. Treatment with levofloxacin for suspected prostatitis was un- successful in reversing symptoms, and the patient required further eval- uation. Upon re-examination a left perineal mass was detected. Com- puted tomography of the area revealed a hypoattenuating mass consistent with a prostate abscess. Treatment included surgical drain- age. Examination and culture of the drainage fluid revealed an acid fast bacilli infection (Mycobacterium bovis), which was treated with isoniazid and ethambutol. Continued treatment with this regimen was in progress at the time of publication. The authors noted that this is the first case report of prostate abscess after bacillus Calmette-Gurin therapy for bladder cancer. They sug- gested that prompt initiation of antituberculin therapy is essential in opti- mizing beneficial patient outcomes. Bacillus Calmette-Gurin ["TICE," "TheraCys"] Matlaga BR et al (Dept Urology, Wake Forest Univ, Sch Med, Winston-Salem, NC) Prostate abscess following intravesical bacil- lus Calmette-Gurin
Loading next page...
Problems Reading this Article? Report Issue Here

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for only $40/month.

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.